These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain. Deng L; Cornett BL; Mackie K; Hohmann AG Mol Pharmacol; 2015 Jul; 88(1):64-74. PubMed ID: 25904556 [TBL] [Abstract][Full Text] [Related]
7. Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit. Slivicki RA; Saberi SA; Iyer V; Vemuri VK; Makriyannis A; Hohmann AG J Pharmacol Exp Ther; 2018 Dec; 367(3):551-563. PubMed ID: 30275151 [TBL] [Abstract][Full Text] [Related]
8. The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB₂ receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy. Deng L; Guindon J; Vemuri VK; Thakur GA; White FA; Makriyannis A; Hohmann AG Mol Pain; 2012 Sep; 8():71. PubMed ID: 22998838 [TBL] [Abstract][Full Text]